Interleukin-8 (IL-8), one of the ELR+ CXC families of chemokines, is a potent pro-angiogenic factor and furthermore, its expression is associated with angiogenesis, tumour progression and survival in patients with non-small cell lung cancer (NSCLC) [20-27]. This evidence concerns the gene CXCL8 and neoplasm.